Drug maker hikes price of 2-in-1 painkiller >2,000%—$36 drugs now $3,000

Enlarge (credit: Getty | Mario Tama)

Irish drug company Horizon Pharma has hiked the price of a two-in-one painkiller by more than 2,000 percent in the past five years, according to a report in Financial Times

A 60-pill bottle of the drug combo, Vimovo, cost $ 138 in 2013 when AstraZeneca sold it to Horizon. The bottle now costs $ 2,979 after Horizon raised the price on 11 occasions.

Vimovo is a combination of the common painkiller naproxen and esomeprazole. Naproxen is the active ingredient in Bayer’s over-the-counter painkiller Aleve. A side effect of naproxen is gastrointestinal issues, including stomach pain and heartburns. As such, Vimovo combines it with esomeprazole, a proton-pump inhibitor that treats heartburn. Esomeprazole is sold over the counter by AstraZeneca as Nexium.

Read 6 remaining paragraphs | Comments

Post Author: martin

Avatar
Martin is an enthusiastic programmer, a webdeveloper and a young entrepreneur. He is intereted into computers for a long time. In the age of 10 he has programmed his first website and since then he has been working on web technologies until now. He is the Founder and Editor-in-Chief of BriefNews.eu and PCHealthBoost.info Online Magazines. His colleagues appreciate him as a passionate workhorse, a fan of new technologies, an eternal optimist and a dreamer, but especially the soul of the team for whom he can do anything in the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.